Abstract: The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein X1, Y1, Y2, Z1, Z2, R1, R2, R6, R9 and n are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.

Abstract: Embodiments disclosed herein include to a component support for use in coating chamber components via chemical vapor deposition (CVD). The component support includes contact rods configured to contact chamber components at fixture points located on the backside of the chamber components. The component supports are configured to support the chamber components in the processing volume with minimal contact of the chamber components. The fixture points on the backside reduce exposure of the fixture points to reactant gases when the chamber components are installed.

Abstract: A susceptor for use in a processing chamber for supporting a wafer includes a susceptor substrate having a susceptor ledge on an outer circumferential edge of a front side of the susceptor substrate, wherein a pocket within the susceptor ledge is configured to hold a wafer to be processed in a processing chamber, and a coating layer deposited on the susceptor substrate, wherein a surface of the susceptor ledge is textured with a plurality of venting groove lines, a surface of the pocket is textured with a first pattern, and a surface of a back side of the susceptor substrate opposite the front side is textured with a second pattern.

Abstract: An electrical component includes a magnetic core, an insulator, and a first winding. The insulator includes a first aperture disposed about a first portion of the core and a first insulator passage extending through the insulator, encircling the first aperture. The first winding extends through the first insulator passage and conducts an electrical current.

Abstract: The present invention relates to compounds of Formula (I), or an agronomically acceptable salt of said compounds wherein A1, A2, A3, Q, X, R1 and R2 are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of Formula (I) and to the use of compounds of Formula (I) for controlling weeds, in particular in crops of useful plants.

Abstract: An improved method for zero-voltage switching (ZVS) of a voltage-fed half-bridge using a variable dead band is provided. The duration of the dead band is determined dynamically and is precisely long enough to ensure the absence of shoot-through events while also minimizing or eliminating switching losses and reverse conduction losses. The method generally includes: (a) calculating the equivalent capacitance as seen by the current source charging the midpoint of the half-bridge; (b) calculating the ZVS charge requirement based on the link voltage and the equivalent capacitance; (c) calculating the charge delivered by the current source over time during a dead band vector, equating the result to the ZVS charge requirement, and solving for the ZVS time requirement at each commutation point over the switching cycle; and (d) updating the dead bands for each commutation of each half-bridge in the switched-mode power converter.

Abstract: A method of controlling an adjustable chair comprising the steps of measuring the height of a person, entering the height of the person into a software application on a mobile device, taking a photograph of the person with a mobile device, analyzing the photograph to determine physical measurements of the person, storing the measurements in the mobile device; calculating optimum ergonomic adjustment of the chair based upon the stored measurements; and, transmitting signals to a controller in the chair to control actuators and adjust various components in the chair to achieve optimum ergonomic adjustment. The technology also includes the ergonomic task chair adjusted by the aforementioned method.

Abstract: A headgear for use with a patient interface for delivering a flow of breathable gas to a patient includes at least a strap adapted to position the patient interface in sealing engagement with the patient’s airways. The strap is constructed from an elastomer and a first side of the strap includes a first region on a portion of its surface that is textured to reduce friction with objects contacting the strap. A textured surface coating for a portion of an elastomer strap included in a headgear system is adapted to contact the skin of a patient, when in use, and the coating has a Ra value greater than zero. A vent for use with a patient interface for delivering a flow of breathable gas to a patient includes a plurality of rises and runs in a stepped arrangement; and a plurality of holes in the stepped arrangement for the venting of gas.

Abstract: Described are cable joints and related structures and techniques for coupling high temperature superconducting (HTS) cables. A cable joint includes a conductive member having a length which defines the length of the joint and having first and second mounting regions shaped to accept first and second HTS cable with an interface layer comprised of a malleable metal disposed between a surfaces of the first and second mounting regions and surfaces of the first and second HTS cables.

Abstract: Described herein are concepts, system and techniques which provide a means to construct robust high-field superconducting magnets using simple fabrication techniques and modular components that scale well toward commercialization. The resulting magnet assembly—which utilizes non-insulated, high temperature superconducting tapes (HTS) and provides for optimized coolant pathways—is inherently strong structurally, which enables maximum utilization of the high magnetic fields available with HTS technology. In addition, the concepts described herein provide for control of quench-induced current distributions within the tape stack and surrounding superstructure to safely dissipate quench energy, while at the same time obtaining acceptable magnet charge time. The net result is a structurally and thermally robust, high-field magnet assembly that is passively protected against quench fault conditions.

Abstract: Devices and methods for transplanting cells in a host body are described. The cell comprises a porous scaffold that allows the ingrowth of vascular and connective tissues, a plug or plug system configured for placement within the porous scaffold, and a seal configured to enclose a proximal opening in the porous scaffold. The device may further comprise a cell delivery device for delivering cells into the porous scaffold. The method of cell transplantation comprises a two step process. The device is incubated in the host body to form a vascularized collagen matrix around a plug positioned within the porous scaffold. The plug is then retracted from the porous scaffold, and cells are delivered into the vascularized space created within the porous scaffold.

Abstract: Aspects relate to changing at least one communication parameter. In some examples, the at least one communication parameter may include at least one of an association identifier (AID), a packet number (PN), a sequence number (SN), a traffic identifier (TID), a timing synchronization function (TSF) value, or a combination thereof. In some examples, a first apparatus provides an indication of a change associated with at least one of the AID, the PN, the SN, the TID, the TSF value, or a combination thereof to a second apparatus.

Abstract: A rocker arm includes an outer arm having a first side and a second side, an inner arm positioned between the first side and the second side of the outer arm, a pivot axle pivotally coupling the inner arm to the outer arm at a first end of the inner arm and a first end of the outer arm, and a latch pin having a first position and a second position. The latch pin in the first position pivotally fixes the inner arm to the outer arm at a second end of each of the inner arm and a second end of the outer arm, and in the second position allows the inner arm and the outer arm to pivot independently. Two lost motion springs are respectively secured to mounts provided on the outer arm.

Abstract: Communications systems and methods for communicating data are provided. In one example, the communications system includes an outer ring having an inner surface and an inner ring having an outer surface. The inner surface and the outer surface are separated by a gap that extends around the inner ring to define a loop. A modulating light arrangement receives data and produces modulated light. A first light diffusing optical fiber and a second light diffusing optical fiber are disposed on a first side of the gap and extend in the loop to define an optical data ring. The first light diffusing optical fiber and the second light diffusing optical fiber cooperate to diffuse the modulated light along the optical data ring. A detector is disposed on the second side of the gap and detects the diffuse modulated light.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of delta opioid receptor, biased and/or unbiased, and/or methods for treating pain, migraines, headaches, depression, Parkinsons Disease, anxiety, and/or overactive bladder, and other disorders and conditions described herein or any combination thereof.

Abstract: A data processor, such as a graphics processor, is disclosed. The data processor includes a set of one or more counters, and a control circuit that maintains a cache-like pool of corresponding entries. In response to a request for a counter, the control circuit may allocate an entry of the cache-like pool to thereby allocate a counter of the set.

Abstract: A patient interface assembly is configured to deliver pressurized respiratory gas to a patient's airways. The patient interface assembly includes a cushion configured to sealingly engage the patient's face, a plenum base supporting the cushion, and a positioning and stabilizing structure configured to support the cushion and the plenum base on the patient's face. The positioning and stabilizing structure includes a stiffened portion. The patient interface assembly further includes a removable sleeve. The stiffened portion of the positioning and stabilizing structure is inserted into the removable sleeve. The removable sleeve is configured to be secured to the stiffened portion of the positioning and stabilizing structure by inserting a projection into a side cutout, and the stiffened portion of the positioning and stabilizing structure is prevented from sliding out of the removable sleeve when the projection is received within the side cutout.

Abstract: Certain aspects of the present disclosure relate to wireless communications. According to certain aspects, a method that may be performed by an access point (AP) includes outputting, for transmission to an access point (AP), a request to associate with the AP, wherein the request is encrypted with a first set of one or more keys; obtaining, from the AP, a response to the request; decrypting the response, based on the first set of keys, to obtain a second set of one or more keys; and using the second set of keys for secure data exchange with the AP.

Abstract: Devices and methods for transplanting cells in a host body are described. The cell comprises a porous scaffold that allows ingrowth of vascular and connective tissues, a plug or plug system configured for placement within the porous scaffold, and a seal configured to enclose a proximal opening in the porous scaffold. The device may further comprise a cell delivery device for delivering cells into the porous scaffold. The method of cell transplantation comprises a two step process. The device is incubated in the host body to form a vascularized collagen matrix around a plug positioned within the porous scaffold. The plug is then retracted from the porous scaffold, and cells are delivered into the vascularized space created within the porous scaffold.

Abstract: The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S1P1 receptor and methods of using the same.